Novakand Pharma AB (publ) (STO:NOVKAN)
0.0401
-0.0049 (-10.89%)
At close: Mar 27, 2026
-96.66% (1Y)
| Market Cap | 4.86M -96.6% |
| Revenue (ttm) | n/a |
| Net Income | -47.23M |
| EPS | -0.39 |
| Shares Out | 121.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,728,972 |
| Average Volume | 999,309 |
| Open | 0.0450 |
| Previous Close | 0.0450 |
| Day's Range | 0.0400 - 0.0450 |
| 52-Week Range | 0.0356 - 2.2500 |
| Beta | 0.92 |
| RSI | 27.54 |
| Earnings Date | Apr 24, 2026 |